The Use of Probiotic Therapy to Modulate the Gut Microbiota and Dendritic Cell Responses in Inflammatory Bowel Diseases
Authors:
- Pablo Alagón Fernández del CampoPCPablo Alagón Fernández del Campo
- Alejandro De Orta PandoAPAlejandro De Orta Pando
- Juan Ignacio StrafaceJSJuan Ignacio Straface
- José Ricardo López VegaJVJosé Ricardo López Vega
- Diego Toledo PlataDPDiego Toledo Plata
- Sebastian Felipe Niezen LugoSLSebastian Felipe Niezen Lugo
- Diego Alvarez HernándezDHDiego Alvarez Hernández
- Tomás Barrientos FortesTFTomás Barrientos Fortes
- Laila Gutiérrez-KobehLGLaila Gutiérrez-Kobeh
- Sandra Georgina Solano-GálvezSSSandra Georgina Solano-Gálvez
- Rosalino Vázquez-LópezRVRosalino Vázquez-López
Open Access
- 22 February 2019
- journal article
- review article
- Published by MDPI AG in Medical Sciences
- Vol. 7 (2) , 33
Abstract
Recent investigations have shown that different conditions such as diet, the overuse of antibiotics or the colonization of pathogenic microorganisms can alter the population status of the intestinal microbiota. This modification can produce a change from homeostasis to a condition known as imbalance or dysbiosis; however, the role-played by dysbiosis and the development of inflammatory bowel diseases (IBD) has been poorly understood. It was actually not until a few years ago that studies started to develop regarding the role that dendritic cells (DC) of intestinal mucosa play in the sensing of the gut microbiota population. The latest studies have focused on describing the DC modulation, specifically on tolerance response involving T regulatory cells or on the inflammatory response involving reactive oxygen species and tissue damage. Furthermore, the latest studies have also focused on the protective and restorative effect of the population of the gut microbiota given by probiotic therapy, targeting IBD and other intestinal pathologies. In the present work, the authors propose and summarize a recently studied complex axis of interaction between the population of the gut microbiota, the sensing of the DC and its modulation towards tolerance and inflammation, the development of IBD and the protective and restorative effect of probiotics on other intestinal pathologies.Keywords
Funding Information
- CICSA, FCS Universidad Anáhuac México, Campus Norte (Project number 201638 - CSNBIAVALR170605171)
This publication has 126 references indexed in Scilit:
- Dysbiosis of fecal microbiota in Crohnʼs disease patients as revealed by a custom phylogenetic microarrayInflammatory Bowel Diseases, 2010
- Oral tolerance to food-induced systemic anaphylaxis mediated by the C-type lectin SIGNR1Nature Medicine, 2010
- Induction of Intestinal Th17 Cells by Segmented Filamentous BacteriaCell, 2009
- A Crohn's disease–associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1Nature Immunology, 2009
- Toll-like receptor 2–dependent induction of vitamin A–metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunityNature Medicine, 2009
- Retinoic acid-dependent regulation of immune responses by dendritic cells and macrophagesSeminars in Immunology, 2009
- Toll-Like Receptor 6 Drives Differentiation of Tolerogenic Dendritic Cells and Contributes to LcrV-Mediated Plague PathogenesisCell Host & Microbe, 2008
- TGF-β: A Master of All T Cell TradesCell, 2008
- Division of labor, plasticity, and crosstalk between dendritic cell subsetsCurrent Opinion in Immunology, 2008
- Disruption of E-Cadherin-Mediated Adhesion Induces a Functionally Distinct Pathway of Dendritic Cell MaturationImmunity, 2007